HomeCompareCAIHF vs SBUX

CAIHF vs SBUX: Dividend Comparison 2026

CAIHF yields 714.29% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CAIHF wins by $1074071.35M in total portfolio value
10 years
CAIHF
CAIHF
● Live price
714.29%
Share price
$0.28
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1074071.51M
Annual income
$842,144,038,884.19
Full CAIHF calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — CAIHF vs SBUX

📍 CAIHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCAIHFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CAIHF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CAIHF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CAIHF
Annual income on $10K today (after 15% tax)
$60,714.29/yr
After 10yr DRIP, annual income (after tax)
$715,822,433,051.56/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, CAIHF beats the other by $715,822,377,087.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CAIHF + SBUX for your $10,000?

CAIHF: 50%SBUX: 50%
100% SBUX50/50100% CAIHF
Portfolio after 10yr
$537035.83M
Annual income
$421,072,052,362.15/yr
Blended yield
78.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

CAIHF
No analyst data
Altman Z
2.5
Piotroski
7/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CAIHF buys
0
SBUX buys
0
No recent congressional trades found for CAIHF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCAIHFSBUX
Forward yield714.29%2.75%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$1074071.51M$157.5K
Annual income after 10y$842,144,038,884.19$65,840.13
Total dividends collected$1055362.50M$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: CAIHF vs SBUX ($10,000, DRIP)

YearCAIHF PortfolioCAIHF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$82,129$71,428.57$11,107$407.21+$71.0KCAIHF
2$636,132$548,254.82$12,512$626.87+$623.6KCAIHF
3$4,649,395$3,968,733.31$14,366$978.69+$4.64MCAIHF
4$32,084,076$27,109,223.13$16,929$1,557.50+$32.07MCAIHF
5$209,164,159$174,834,198.35$20,658$2,543.80+$209.14MCAIHF
6$1,289,028,186$1,065,222,534.95$26,406$4,302.22+$1289.00MCAIHF
7$7,514,502,356$6,135,242,197.78$35,877$7,622.00+$7514.47MCAIHF
8$41,466,620,398$33,426,102,876.85$52,741$14,352.64+$41466.57MCAIHF
9$216,754,645,306$172,385,361,480.07$85,676$29,243.03+$216754.56MCAIHF
10$1,074,071,509,362$842,144,038,884.19$157,513$65,840.13+$1074071.35MCAIHF

CAIHF vs SBUX: Complete Analysis 2026

CAIHFStock

Chia Tai Enterprises International Limited engages in the manufacture and sale of chlortetracycline (CTC) and other related products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment manufactures and sells CTC premix and CTC hydrochloride products, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brands. The Industrial segment engages in the sale, leasing, and servicing of caterpillar machinery equipment, including excavators, power generators, bulldozers, and compactors, as well as spare parts; and manufacture and sale of carburetors and automotive parts for automobile and motorcycle manufacturers. The company was incorporated in 1987 and is based in Central, Hong Kong. Chia Tai Enterprises International Limited is a subsidiary of Charoen Pokphand Foods Public Company Limited.

Full CAIHF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this CAIHF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CAIHF vs SCHDCAIHF vs JEPICAIHF vs OCAIHF vs KOCAIHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.